[{"title": "CytomX Therapeutics Inc. (CTMX) Stock Price Today - WSJ", "url": "https://www.wsj.com/market-data/quotes/US/CTMX", "snippet": "View the latest CytomX Therapeutics Inc. (CTMX) stock price, news, historical charts, analyst ratings and financial information from WSJ.", "published": "2025-08-12T21:11:00+00:00"}, {"title": "CytomX Therapeutics: Updated Outlook For Late 2025", "url": "https://seekingalpha.com/article/4811453-cytomx-therapeutics-updated-outlook-for-late-2025", "snippet": "CytomX Therapeutics' innovative cancer therapies show promise with the CX-2051 and CX-801 trials. Explore the potential of CTMX probody technology. Click to read more.", "published": "2025-08-08T21:06:00+00:00"}, {"title": "Oppenheimer Initiates Coverage of CytomX Therapeutics (CTMX) with Outperform Recommendation", "url": "https://www.msn.com/en-us/money/savingandinvesting/oppenheimer-initiates-coverage-of-cytomx-therapeutics-ctmx-with-outperform-recommendation/ar-AA1JGRUr", "snippet": "Fintel reports that on July 31, 2025, Oppenheimer initiated coverage of CytomX Therapeutics (NasdaqGS:CTMX) with a Outperform recommendation. Analyst Price Forecast Suggests 141.81% Upside As of July 17,", "published": "2025-07-31T21:04:54+00:00"}, {"title": "CytomX Therapeutics (CTMX) Reports Break-Even Earnings for Q2", "url": "https://www.msn.com/en-us/money/general/cytomx-therapeutics-ctmx-reports-break-even-earnings-for-q2/ar-AA1K7fMN", "snippet": "CytomX Therapeutics (CTMX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.", "published": "2025-08-07T21:25:02+00:00"}]